SyntekaBio,Inc.
An AI-driven drug discovery company using supercomputing to accelerate development.
226330 | KO
Overview
Corporate Details
- ISIN(s):
- KR7226330009
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 국제과학17로 18 -, 대전광역시
- Website:
- https://www.syntekabio.com/
Description
SyntekaBio is an AI-driven drug discovery company that utilizes its proprietary supercomputing infrastructure, the AI Bio-Supercom Center, to accelerate pharmaceutical development. The company's core technology, the DeepMatcher® platform, underpins a suite of services for discovering small molecules, antibodies, and neoantigens for personalized cancer vaccines. A key offering is LaunchPad, a factory-like system that continuously generates a stream of 'off-the-shelf' drug candidates for numerous disease targets, aiming to expedite the path to IND-enabling studies. SyntekaBio delivers its solutions through comprehensive discovery partnerships and a modular, cloud-based Software as a Service (SaaS) platform, STB CLOUD, providing researchers with automated tools for drug development and genomics analysis.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-03-09 00:00 |
[기재정정]의결권대리행사권유참고서류
|
Korean | 156.6 KB | ||
| 2021-03-02 00:00 |
주주총회소집공고
|
Korean | 142.8 KB | ||
| 2021-03-02 00:00 |
의결권대리행사권유참고서류
|
Korean | 154.2 KB | ||
| 2021-03-02 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.0 KB | ||
| 2021-02-26 00:00 |
주식매수선택권부여에관한신고
|
Korean | 14.4 KB | ||
| 2021-02-26 00:00 |
주주총회소집결의
|
Korean | 8.8 KB | ||
| 2021-02-15 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.1 KB | ||
| 2021-01-20 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2021-01-19 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.5 KB | ||
| 2020-12-16 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2020-12-11 00:00 |
[기재정정]기타경영사항(특허권취득)(자율공시)(제2형 중증급성호흡기증후군 코로나바이러스 감염 질환의 예방 또는 치료용 조성물)
|
Korean | 8.9 KB | ||
| 2020-11-16 00:00 |
분기보고서 (2020.09)
|
Korean | 728.3 KB | ||
| 2020-10-19 00:00 |
기타경영사항(특허권취득)(자율공시)(제2형 중증급성호흡기증후군 코로나바이러스 감염 질환의 예방 또는 치료용 조성물)
|
Korean | 5.9 KB | ||
| 2020-09-14 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 76.9 KB | ||
| 2020-08-14 00:00 |
반기보고서 (2020.06)
|
Korean | 625.4 KB |
Automate Your Workflow. Get a real-time feed of all SyntekaBio,Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SyntekaBio,Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SyntekaBio,Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
